MBLVC
MBL Venture Capital Co. Ltd. is the investment arm of Medical & Biological Laboratories Co., Ltd. The firm primarily invests in seed, start-up, early, middle to later stage venture companies, including university and research institute-based ventures. It prefers to invest mainly in biotechnology, life science, drug discovery and regenerative medicine sectors in conjunction with IT applications, some of which are bio-informatics, medical diagnostics and devices, and medical services among others. The firm typically invests in Japan and companies overseas. It prefers to have majority stakes in its portfolio companies. MBL Venture Capital Co., Ltd. was established on January 12, 2000 and is headquartered in Nagoya, Japan with an additional office in Tokyo, Japan.
MBLVC
Founded:
2000-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Euro Amazon Route 53
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-07-30 | J-Pharma | MBLVC investment in Series D - J-Pharma | 1.75 M JPY |
2018-03-30 | Himuka AM Pharma | MBLVC investment in Seed Round - Himuka AM Pharma | 350 M JPY |
2017-04-04 | Sentien Biotechnologies | MBLVC investment in Series A - Sentien Biotechnologies | 12 M USD |
2016-12-28 | Kinopharma | MBLVC investment in Venture Round - Kinopharma | 250 M JPY |
2016-04-13 | Second Genome | MBLVC investment in Series B - Second Genome | 51 M USD |
2014-08-29 | BrightPath Biotherapeutics | MBLVC investment in Venture Round - BrightPath Biotherapeutics | 1.2 B JPY |
2014-04-04 | Sentieon | MBLVC investment in Series A - Sentieon | 3.8 M USD |
2011-11-01 | TMS | MBLVC investment in Seed Round - TMS | 36.25 M JPY |